- Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events2013 | Lékařská fakulta v Hradci Králové, 3. lékařská fakulta
- Early and Late Benefits of Prasugrel in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: A TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) Analysis2008 | 3. lékařská fakulta
- Predictors of bleeding in patients with acute coronary syndromes treated with prasugrel2015 | 3. lékařská fakulta
- Bridging Antiplatelet Therapy With Cangrelor in Patients Undergoing Cardiac Surgery A Randomized Controlled Trial2012 | Publikace bez příslušnosti k fakultě
- A comparison of prasugrel at the time of percutaneous coronary intervention or as pretreatment at the time of diagnosis in patients with non-ST-segment elevation myocardial infarction: design and rationale for the ACCOAST study2011 | 3. lékařská fakulta
- Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial2013 | 3. lékařská fakulta
- Ticagrelor in Patients with Stable Coronary Disease and Diabetes2019 | 3. lékařská fakulta
- Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes2010 | 3. lékařská fakulta
- Characterising and predicting bleeding in high-risk patients with an acute coronary syndrome2015 | Publikace bez příslušnosti k fakultě
- Response by Motovska et al to Letter Regarding Article, "Prasugrel Versus Ticagrelor in Patients With Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Multicenter Randomized PRAGUE-18 Study"2017 | 3. lékařská fakulta, Ústřední knihovna
- Antiplatelet efficacy of P2Y12 inhibitors (prasugrel, ticagrelor, clopidogrel) in patients treated with mild therapeutic hypothermia after cardiac arrest due to acute myocardial infarction2016 | Matematicko-fyzikální fakulta, 3. lékařská fakulta
- Clopidogrel up-titration versus standard dose in patients with high residual platelet reactivity after percutaneous coronary intervention: A single-center pilot randomised study2011 | 3. lékařská fakulta
- Evaluation of Aspirin's Effect on Platelet Function Early After Coronary Artery Bypass Grafting2012 | Matematicko-fyzikální fakulta, 3. lékařská fakulta
- Safety and Efficacy of Cangrelor, an Intravenous, Short-Acting Platelet Inhibitor in Patients Requiring Coronary Artery Bypass Surgery2013 | Publikace bez příslušnosti k fakultě
- Nedostatečná účinnost antitrombotické léčby - klinické souvislosti a současné názory na její laboratorní hodnocení +12009 | Lékařská fakulta v Hradci Králové
- Nedostatečná účinnost antitrombotické léčby - klinické souvislosti a současné názory na její laboratorní hodnocení2009 | 1. lékařská fakulta
- Antiplatelet effect of prasugrel and clopidogrel in hypothermic patients after cardiac arrest for acute myocardial infarction2014 | Matematicko-fyzikální fakulta, 3. lékařská fakulta
- Contemporary registries on P2Y12 inhibitors in patients with acute coronary syndromes in Europe: overview and methodological considerations2015 | 3. lékařská fakulta
- Optimální načasování předléčby vysokou dávkou clopidogrelu (600mg) před plánovanou perkutánní koronární intervencí s cílem dosažení maximálního protidestičkového působení2010 | 3. lékařská fakulta, 1. lékařská fakulta
- Clopidogrel is safer than ticagrelor in regard to bleeds: A closer look at the PLATO trial2013 | 2. lékařská fakulta
- Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention2017 | Publikace bez příslušnosti k fakultě
- Design and rationale of CURRENT-OASIS 7: A randomized, 2 x 2 factorial trial evaluating optimal dosing strategies for clopiclogrel and aspirin in patients with ST and non-ST-elevation acute coronary syndromes managed with an early invasive strategy2008 | 3. lékařská fakulta
- Inactivations, deletions, non-adjudications, and downgrades of clinical endpoints on ticagrelor: Serious concerns over the reliability of the PLATO trial2013 | 2. lékařská fakulta
- Clinical outcomes for prasugrel versus clopidogrel in patients with unstable angina or non-ST-elevation myocardial infarction: an analysis from the TRITON-TIMI 38 trial2014 | 3. lékařská fakulta
- Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIXPublikace bez příslušnosti k fakultě